Costly cancer drug to be covered by Medicare

(By – Robert Pear, THE NEW YORK TIMES)

The Obama administration has decided that Medicare will pay for one of the newest, most-expensive cancer medications, which costs about $178,000 for a standard course of treatment. Read more…

Notice: The “Read more…” link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.